Allergies is a reaction of hypersensitivity of the immune system to usually harmless substances that can be absorbed dermally or encounter with body. They trouble more than 40 % of the world's population (https://www.aaaai.org/about-aaaai/newsroom/allergy-statistics). According to The World Health Organization (WHO) statistics, by 2025, more than 50% of the population of large cities will have had some form of allergy.
There are many factors that cause allergies/ They are constantly increasing. The most common are: airborne allergens such as pollen, animal dander, dust mites and mold (fungal spores); certain foods, such as peanuts, nuts, wheat, soy, fish, shellfish, eggs, and milk; insect bites; medications; latex, and other substances that people touch.
The pharmaceutical industry is constantly developing in this direction. Scientists are developing new molecules that are aimed to help people with allergies. Levocetirizine is one of the last molecules, that even has won the Nobel prize in 2001.
Kiev vitamin plant, which has GMP-approved certificates, has released the medicine Ergocetal (levocetirizine). Ergocetal is effective on both early and late stages of the allergic reactions. It also has an anti-inflammatory effect. It begins its action within 12 minutes after taking a single dose in 50% of patients, within an hour – in 95% of patients, as well as its effect lasts more than 24 hours.
Ergocetal is for symptomatic treatment of allergic rhinitis (including perennial allergic rhinitis) and urticaria. The daily dose is 1 tablet (5 mg) once a day. The duration of treatment depends on the manifestations of allergies, and can even last up to a year.
Ergocetal is the best choice!